Saudi-based healthtech startup Madeed has closed a $925,000 pre-seed round to accelerate the development of its personalised preventive healthcare platform.
The round saw participation from SEEDRA Ventures, Unity Investment Partners, and Seen Growth, alongside previously announced backers including Vision Ventures and a group of Saudi angel investors.
The fresh capital will be used to further build Madeed’s product offering and expand its clinical and laboratory partnerships, with an initial focus on scaling across Saudi Arabia.
Founded by Dr. Adam Batayneh, Madeed is positioning itself at the intersection of AI, longevity, and preventive care. The platform leverages advanced lab data and artificial intelligence to detect early risk indicators for hundreds of diseases—before symptoms appear—while offering personalised health plans and nutritional recommendations tailored to individual lifestyles.
“We are proud of the partnerships we are building with a select group of organisations and companies, reflecting a high level of awareness regarding the importance of preventative healthcare,” said Batayneh. “We are optimistic about the results achieved so far, having attracted 150 subscribers during the pilot phase, which we consider a clear indicator of the expected demand upon the official launch.”
Madeed claims to be among the first platforms in the Middle East focused on proactive, personalised healthcare and longevity. As demand grows for preventive and data-driven health solutions, the startup is aiming to play a key role in reshaping how healthcare is delivered across the region.
